The University of Manchester Academic Health Science Centre (MAHSCH), part of Health Innovation Manchester, was officially designated by National Institute for Health Research (NIHR), NHS England and NHS Improvement up to 2025. The prestigious Academic Health Science Centre (AHSC) designation represents partnerships between top UK-based universities and outstanding NHS organizations collaborating to tackle disease and develop new treatments all to transform care. MAHSC delivers research in six (6) domains, including cancer, cardiovascular, diabetes, inflammation and repair, mental health, neuroscience, and women and children.
This prestigious designation runs from 1 April 2020 up to 2025. MAHSC brings together a number of prominent care and research centers to drive health research to benefit UK citizens. They include:
- The University of Manchester
- Manchester University NHS Foundation Trust (MFT)
- The Christie NHS Foundation Trust
- Salford Royal NHS Foundation Trust (Part of the Northern Care Alliance NHS Group)
- Greater Manchester Mental Health NHS Foundation Trust (GMMH)
COVID-19 has triggered an intense and positive response across Greater Manchester (and, of course, throughout the UK and beyond), evidencing scientists and clinicians’ quest to find ways to beat COVID-19 and save lives. Now with the AHSC established the regional network of investigators will harness the power of hundreds of researchers from the University of Manchester as well as clinical colleagues from the Manchester University NHS Foundation Trust and the Northern Care Alliance NHS Groups, all backed by Health Innovation Manchester (HInM).
During the next five years MAHSC research and innovation will be delivered by six domains, each led jointly by an academic and an NHS clinician and chaired by a Chief Executive from a partner Trust. These domains are:
- Cancer (The Christie) Supporting transformational change in cancer-related life sciences to provide outstanding healthcare.
- Cardiovascular and Diabetes (MFT) Working to eliminate the inequalities in cardiovascular-related outcomes that affect the local population.
- Inflammation and Repair (MFT) Supporting work in dermatology, musculoskeletal, respiratory, gastroenterology, infection, orthopedics, trauma, renal, and regenerative medicine.
- Mental Health (GMMH) Supporting priorities of dementia, self-harm, digital mental health.
- Neuroscience (Salford Royal) Harnessing the local expertise and excellence in neuroscience to improve outcomes.
- Women and Children (MFT) Incorporating the clinical specialties of pediatrics, obstetrics, gynecology and genomics, linking the core specialties that are relevant to promote improvements in health from birth to old age.